Combat Methamphetamine Epidemic Act of 2005

Combat Methamphetamine Epidemic Act of 2005

The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is a federal law in the United States that was enacted with the aim of curbing the production, distribution, and abuse of methamphetamine, a highly addictive and illegal stimulant drug. The Act was signed into law by President George W. Bush on March 9, 2006, as part of the USA PATRIOT Improvement and Reauthorization Act of 2005.

Background

The CMEA was enacted in response to the growing methamphetamine epidemic in the United States during the early 2000s. Methamphetamine, also known as meth, is a powerful stimulant that can be manufactured using common household chemicals and over-the-counter medications containing pseudoephedrine or ephedrine. The ease of production and the highly addictive nature of the drug led to a significant increase in its abuse, resulting in widespread social and health problems.

Provisions

The CMEA includes several key provisions aimed at controlling the sale and distribution of products containing pseudoephedrine, ephedrine, and phenylpropanolamine, which are often used in the illicit production of methamphetamine. These provisions include:

• Mandatory identification checks for individuals purchasing products containing these substances.
• A limit on the amount of these products that an individual can purchase within a 30-day period.
• Requirements for retailers to keep a logbook of sales of these products.
• Increased penalties for the illegal production and distribution of methamphetamine.

Impact

Since its enactment, the CMEA has had a significant impact on the methamphetamine problem in the United States. The Act has led to a decrease in the number of domestic methamphetamine labs, as well as a decrease in the availability of the drug. However, it has also led to an increase in the importation of methamphetamine from foreign sources, particularly from Mexico.

Criticism

Despite its successes, the CMEA has also been subject to criticism. Some argue that the Act has led to an increase in the price of over-the-counter medications and has placed an undue burden on retailers. Others argue that the Act has not done enough to address the root causes of methamphetamine abuse, such as poverty and lack of access to treatment.

See also

• Controlled Substances Act
• Drug Enforcement Administration
• Methamphetamine

   This article is a  stub. You can help WikiMD by expanding it!

This article is a stub related to pharmacology. You can help WikiMD by expanding it!